Physician profile
Sameh R Yonan
NPI 1013092147
$2,675.86
in general payments reported to CMS, 2019-2025
33 companies · $180 in 2025
The $180 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,156 · 2020: $272 · 2021: $361 · 2022: $537 · 2023: $66.93 · 2024: $103 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $349.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $453.02 | 2019-2021 | |
| Abbvie INC. | $270.81 | 2021-2022 | |
| Nevro Corp. | $181.88 | 2019-2022 | |
| Collegium Pharmaceutical, INC. | $157.38 | 2019-2021 | |
| Medtronic, INC. | $138.78 | 2022 | |
| Saluda Medical Americas, INC. | $125.68 | 2022 | |
| Globus Medical, INC. | $121.29 | 2022 | |
| Flowonix Medical Incorporated | $116.68 | 2019 | |
| Boston Scientific Corporation | $110.11 | 2025 | General - Pain Management |
| Mml US, INC. | $102.72 | 2024 | Reactiv8 |
| Novartis Pharmaceuticals Corporation | $85.97 | 2019-2020 | |
| Lilly USA, LLC | $84.87 | 2019-2022 | |
| Assertio Therapeutics, INC. | $72.24 | 2019-2020 | |
| Pfizer INC. | $70.31 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $66.23 | 2019-2025 | Xifaxan |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $58.52 | 2019 | |
| Tersera Therapeutics LLC | $54.72 | 2019 | |
| Stryker Corporation | $51.32 | 2025 | Optablate, Spinejack |
| Medtronic USA, INC. | $45.95 | 2019 | |
| Spr Therapeutics, INC | $41.40 | 2023 | Sprint Pns System |
| Almatica Pharma LLC | $36.24 | 2021 | |
| Scilex Pharmaceuticals INC. | $36.00 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $30.22 | 2019-2020 | |
| Averitas Pharma INC. | $25.53 | 2023 | Qutenza |
| Fidia Pharma USA INC. | $24.29 | 2019 | |
| Nalu Medical, INC. | $18.69 | 2020 | |
| Zyla Life Sciences, INC. | $16.53 | 2019 | |
| Supernus Pharmaceuticals, INC. | $15.83 | 2019 | |
| Allergan, INC. | $14.58 | 2020 | |
| Vertical Pharmaceuticals, LLC | $13.01 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.25 | 2020 | |
| Shionogi INC | $11.76 | 2019 | |
| Bioventus LLC | $11.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameh Yonan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.